- Home
- SSY vs GTBP Comparison
SSY vs GTBP Comparison
Compare SSY & GTBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSY
- GTBP
- Stock Information
- Founded
- SSY 1959
- GTBP 1965
- Country
- SSY United States
- GTBP United States
- Employees
- SSY N/A
- GTBP N/A
- Industry
- SSY Hospital/Nursing Management
- GTBP Biotechnology: Pharmaceutical Preparations
- Sector
- SSY Health Care
- GTBP Health Care
- Exchange
- SSY Nasdaq
- GTBP Nasdaq
- Market Cap
- SSY 5.7M
- GTBP 6.6M
- IPO Year
- SSY N/A
- GTBP N/A
- Fundamental
- Price
- SSY $0.80
- GTBP $2.91
- Analyst Decision
- SSY
- GTBP
- Analyst Count
- SSY 0
- GTBP 0
- Target Price
- SSY N/A
- GTBP N/A
- AVG Volume (30 Days)
- SSY 8.3K
- GTBP 28.9K
- Earning Date
- SSY 11-12-2024
- GTBP 11-14-2024
- Dividend Yield
- SSY N/A
- GTBP N/A
- EPS Growth
- SSY N/A
- GTBP N/A
- EPS
- SSY N/A
- GTBP N/A
- Revenue
- SSY $31,808,000.00
- GTBP N/A
- Revenue This Year
- SSY N/A
- GTBP N/A
- Revenue Next Year
- SSY N/A
- GTBP N/A
- P/E Ratio
- SSY N/A
- GTBP N/A
- Revenue Growth
- SSY N/A
- GTBP N/A
- 52 Week Low
- SSY $0.53
- GTBP $1.92
- 52 Week High
- SSY $1.05
- GTBP $10.66
- Technical
- Relative Strength Index (RSI)
- SSY 45.98
- GTBP 55.53
- Support Level
- SSY $0.79
- GTBP $2.94
- Resistance Level
- SSY $0.86
- GTBP $3.54
- Average True Range (ATR)
- SSY 0.04
- GTBP 0.27
- MACD
- SSY -0.01
- GTBP -0.02
- Stochastic Oscillator
- SSY 8.75
- GTBP 23.05
About SSY SunLink Health Systems Inc.
SunLink Health Systems Inc is engaged in providing retail pharmacy services. The company operates its business through segments namely the Healthcare Services segment and Pharmacy segment. The Healthcare Services segment includes subsidiaries that own and operates nearly 80-licensed-bed, acute care hospitals, which includes more than 18-bed geriatric psychology unit, and over 60-bed nursing home; own medical buildings, which are leased to unaffiliated healthcare providers, and adjacent vacant land; and provides information technology to outside customers. The Pharmacy segment, which is the key revenue generator is composed of retail pharmacy products and services that are conducted in rural markets; institutional pharmacy services; pharmacy services; and durable medical equipment.
About GTBP GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.